Synjardy 5Mg/850Mg 60Tab

Synjardy is a medication belonging to the class of antidiabetic drugs, containing two active ingredients: empagliflozin and linagliptin. This medication is used to manage blood sugar levels in patients with type 2 diabetes. Empagliflozin works by reducing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine, while linagliptin increases insulin secretion and decreases glucagon secretion. This medication is considered part of a comprehensive treatment plan that includes diet and exercise.

Generic Name

Empagliflozin and Linagliptin

Product Type and Composition

Tablets, containing 5 mg of empagliflozin and 850 mg of linagliptin, pack of 60 tablets.

Indications

• Treatment of type 2 diabetes as part of a comprehensive treatment regimen.
• Can be used with other antidiabetic medications if necessary.

Possible Side Effects

• Abdominal pain.
• Nausea.
• Diarrhea.
• Low blood sugar levels.
• Contact a healthcare provider if unusual or severe side effects occur.

How to Use

Take one tablet daily with food, and follow the doctor's instructions carefully. Do not exceed the recommended dose.

Drug Interactions

• Avoid using with other medications that may affect blood sugar levels without consulting a doctor.
• Some medications may affect the effectiveness of Synjardy, so it is advised to inform the doctor about all medications being used.
• Avoid alcohol consumption during treatment.

Warnings for Pregnancy and Lactation

Consult a doctor before using this product if pregnant or breastfeeding.

Warnings and Precautions

• Do not use if there is a history of allergy to any of its components.
• Blood sugar levels should be monitored regularly.
• Use caution in patients with kidney problems.

Storage Instructions

• Store at room temperature (15-25°C) in a dry place.
• Protect the product from light and moisture.
• Keep it in the original packaging until use.
• Keep out of reach of children.